ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,826Medicare Part D Prescriptions Filled, Including Refills

Rank: 565 out of 1383

$318K Total Retail Price of All Prescriptions

Rank: 641 out of 1383

379 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 379 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 379 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 5,852 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LISINOPRIL 317 309 1 3
HYDROCODONE-ACETAMINOPHEN 314 274 S3 2 1
LEVOTHYROXINE SODIUM 260 231 3 4
METFORMIN HCL 233 223 4 8
AMLODIPINE BESYLATE 220 188 5 6
OMEPRAZOLE 194 162 6 5
SIMVASTATIN 148 142 7 2
DIVALPROEX SODIUM 145 123 8 78
CITALOPRAM HBR 138 106 9 15
FUROSEMIDE 126 121 10 7
MIRTAZAPINE 120 110 11 51
HYDROCHLOROTHIAZIDE 120 108 11 10
RISPERIDONE 113 97 13 71
WARFARIN SODIUM 94 89 14 13
NOVOLOG 86 77 15 139
POTASSIUM CHLORIDE 82 79 16 12
GLIPIZIDE 76 72 17 98
LEVEMIR 74 65 18 145
TRAZODONE HCL 69 62 19 36
FLUOXETINE HCL 69 39 19 52
FLUTICASONE PROPIONATE 68 47 21 39
PRAVASTATIN SODIUM 65 50 22 14
GABAPENTIN 65 49 22 11
ZOLPIDEM TARTRATE 63 44 24 17
NAPROXEN 60 48 25 105
LACTULOSE 60 30 25 128
DIGOXIN 58 57 27 59
QUETIAPINE FUMARATE 58 58 27 70
CIPROFLOXACIN HCL 57 52 29 54
METOPROLOL TARTRATE 55 40 30 9
DIOVAN 55 40 30 58
ATENOLOL 54 54 32 16
LEVETIRACETAM 54 14 32 134
CARVEDILOL 53 53 34 24
RANITIDINE HCL 51 32 35 19
FENTANYL 51 51 S2 35 92
NYSTATIN 50 50 37 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 3, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.